文献速递冠心病心力衰竭与心肌病

心脏移植后移植心脏血管病变轨迹的识别与特征:一项基于人群的研究

Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
PubMed 文献 · Circulation · 2020-05-04

该研究纳入4个学术中心2004-2016年的1301例心脏移植受者,通过前瞻性方案监测和4710次冠状动脉造影,采用无监督潜在类别混合模型识别出10年内4种不同的心脏移植血管病变(CAV)轨迹。4种轨迹在独立美国队列中一致重现,并与全因死亡率呈梯度相关;供者年龄、供者男性、供者吸烟、受者血脂异常、II类抗人类白细胞抗原供者特异性抗体和急性细胞排斥≥2R是早期独立预测因素。

要点

  • 心脏移植后10年内可识别出4种CAV轨迹,模型区分度良好(0.92)。
  • 供者年龄、供者男性、供者吸烟、受者血脂异常、II类抗人类白细胞抗原供者特异性抗体和急性细胞排斥≥2R为早期独立预测因素。
  • 4种CAV轨迹与全因死亡率呈梯度相关(P<0.001),支持基于轨迹的早期风险分层。

核心结论

  • 在大型多中心、高度表型化的前瞻性心脏移植受者队列中识别出4种CAV轨迹及其各自的独立预测变量。
  • 结果为基于轨迹的评估提供了基础,可用于早期风险分层、患者监测和临床试验。

研究设计与样本

  • 研究纳入来自4个学术中心(巴黎Pitié-Salpêtrière医院和Georges Pompidou医院、鲁汶天主教大学、洛杉矶Cedars-Sinai)的心脏移植受者,时间跨度为2004-2016年。
  • 患者接受前瞻性、方案化监测,包括重复冠状动脉造影以及系统评估临床、组织学和免疫学参数。
  • 共纳入1301例患者(欧洲队列815例,美国队列486例),移植后中位随访6.6年(四分位距4-9.1年),分析4710次冠状动脉造影。
  • 采用无监督潜在类别混合模型识别CAV轨迹,并确定轨迹的独立预测变量及其与死亡率的关联。

主要发现

  • 识别出4种不同的CAV轨迹:1年时无CAV且随时间无进展(56.3%);1年时无CAV且晚发缓慢CAV进展(7.6%);1年时轻度CAV且随时间轻度进展(23.1%);1年时轻度CAV且加速进展(13.0%)。
  • 该模型区分度良好(0.92),并在美国独立队列中一致重现(区分度0.97)。
  • 6个早期独立预测因素:供者年龄(P<0.001)、供者男性(P<0.001)、供者吸烟(P=0.001)、受者血脂异常(P=0.009)、II类抗人类白细胞抗原供者特异性抗体(P=0.004)、急性细胞排斥≥2R(P=0.028)。
  • 4种CAV轨迹与全因死亡率呈梯度相关(P<0.001)。

临床怎么用

  • 可利用供者年龄、供者男性、供者吸烟、受者血脂异常、II类抗人类白细胞抗原供者特异性抗体和急性细胞排斥≥2R等早期因素对心脏移植受者进行CAV风险分层。
  • 基于CAV轨迹的评估可用于指导心脏移植受者的个体化监测和临床试验设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major contributor of heart transplant recipient mortality. Little is known about the prototypes of CAV trajectories at the population level. We aimed to identify the different evolutionary profiles of CAV and to determine the respective contribution of immune and nonimmune factors in CAV development. METHODS: Heart transplant recipients were from 4 academic centers (Pitié-Salpêtrière and Georges Pompidou Hospital, Paris, Katholieke Universiteit Leuven, and Cedars-Sinai, Los Angeles; 2004-2016). Patients underwent prospective, protocol-based monitoring consisting of repeated coronary angiographies together with systematic assessments of clinical, histological, and immunologic parameters. The main outcome was a prediction for CAV trajectory. We identified CAV trajectories by using unsupervised latent class mixed models. We then identified the independent predictive variables of the CAV trajectories and their association with mortality. RESULTS: A total of 1301 patients were included (815 and 486 in the European and US cohorts, respectively). The median follow-up after transplantation was 6.6 (interquartile range, 4-9.1) years with 4710 coronary angiographies analyzed. We identified 4 distinct profiles of CAV trajectories over 10 years. The 4 trajectories were characterized by (1) patients without CAV at 1 year and nonprogression over time (56.3%), (2) patients without CAV at 1 year and late-onset slow CAV progression (7.6%), (3) patients with mild CAV at 1 year and mild progression over time (23.1%), and (4) patients with mild CAV at 1 year and accelerated progression (13.0%). This model showed good discrimination (0.92). Among candidate predictors assessed, 6 early independent predictors of these trajectories were identified: donor age (P<0.001), donor male sex (P<0.001), donor tobacco consumption (P=0.001), recipient dyslipidemia (P=0.009), class II anti-human leukocyte antigen donor-specific antibodies (P=0.004), and acute cellular rejection ≥2R (P=0.028). The 4 CAV trajectories manifested consistently in the US independent cohort with similar discrimination (0.97) and in different clinical scenarios, and showed gradients for overall-cause mortality (P<0.001). CONCLUSIONS: In a large multicenter and highly phenotyped prospective cohort of heart transplant recipients, we identified 4 CAV trajectories and their respective independent predictive variables. Our results provide the basis for a trajectory-based assessment of patients undergoing heart transplantation for early risk stratification, patient monitoring, and clinical trials. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04117152.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Loupy A, Coutance G, Bonnet G, et al. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study. Circulation. 2020. PMID: 32363949. doi:10.1161/CIRCULATIONAHA.119.044924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。